Showing 1–12 of 65 results

Show sidebar

CABOZANIX 20 MG

Product Description: Cabozanix is a multiple Tyrosine Kinase inhibitor that is indicated for the treatment of Renal Cell Carcinoma and

CABOZANIX 80 MG

Product Description: Cabozanix is a multiple Tyrosine Kinase inhibitor that is indicated for the treatment of Renal Cell Carcinoma and

COVIRIN 200MG

Covirin Capsule 200 mg Indications Ribavirin is indicated for the treatment of chronic hepatitis C (CHC) virus infection in combination with

Elbonix 50

COMPOSITION Elbonix 50 tablet : Each film coated tablet contains EltrombopagOlamine INN equivalent to Eltrombopag 50 mg. Therapeutic class: Hematopoietic Agent PHARMACOLOGICAL

ELOPAG 25 MG

 Elopag Tablet Eltrombopag Olamine 25 mg Everest Pharmaceuticals Ltd. Indications Eltrombopag Olamine is indicated in Chronic Immune (Idiopathic) Thrombocytopenia, Chronic Hepatitis

ELOPAG 50 MG

 Elopag Tablet Eltrombopag Olamine 50 mg Everest Pharmaceuticals Ltd.  Also available as: 25 mg Indications Eltrombopag Olamine is indicated in Chronic

ELTROM 25 MG

DESCRIPTION ELTROM Eltrombopag 25MG Julphar Bangladesh Ltd. Composition: Eltrom Tablet: Each film coated tablet contains Eltrombopag Olamine INN equivalent to

HEPANIB 200 MG

 Hepanib Tablet Sorafenib Tosylate 200 mg Everest Pharmaceuticals Ltd.  Indications Hepatocellular Carcinoma: Sorafenib is indicated for the treatment of patients with

HERNIX 40 MG

 Hernix Tablet Neratinib 40 mg Beacon Pharmaceuticals Ltd. Indications Neratinib is a kinase inhibitor indicated for the extended adjuvant treatment of

IBRUNIB 140 MG

IBRUNIB Strength 140 mg Packing 1 X 30 Capsules (Plastic Container) Storage Store below 30°C. Keep capsules in the original